| http://www.w3.org/ns/prov#value | - Objectives: (1) To compare the 1-year clinical efficacy (= the predefined combined end-point) of coumarin and aspirin versus aspirin in patients with severe (a)symptomatic LVD by 2D-echo. (2) To evaluate flow patterns within the two groups and relate normal and abnormal left ventricular flow with predefined combined endpoint and formation of left ventricular thrombus. (3) To compare safety with re
|
